Bioventus, a global leader in orthobiologic solutions, is launching DUROLANE, its single-injection joint-fluid osteoarthritis (OA) treatment, in Malaysia and has selected Athrotech as its exclusive distribution partner for the market. OA involves the breakdown, or degeneration, of cartilage and the synovial fluid that cushions and lubricates joint tissues. It’s estimated that up to 20% of the adult population of Malaysia suffers from osteoarthritis and the most common form of OA in the coun...

Bioventus, a global leader in orthobiologic solutions, is launching DUROLANE, its single-injection joint-fluid osteoarthritis (OA) treatment, in Malaysia and has selected Athrotech as its exclusive distribution partner for the market. OA involves the breakdown, or degeneration, of cartilage and the synovial fluid that cushions and lubricates joint tissues. It’s estimated that up to 20% of the adult population of Malaysia suffers from osteoarthritis and the most common form of OA in the coun...

MSCI Inc. (NYSE: MSCI), a leading provider of indexes, portfolio analytics, and services for global investors, today announced its latest factor innovation, the MSCI Multi-Asset Class Factor Model (MSCI MAC Factor Model), a multi-tiered model that helps investors analyze key portfolio exposures across asset classes through an integrated and consistent framework. Over the last decade, technology, regulatory changes, and the popularity of passive investments have continued to disrupt the active...

MSCI Inc. (NYSE: MSCI), a leading provider of indexes, portfolio analytics, and services for global investors, today announced its latest factor innovation, the MSCI Multi-Asset Class Factor Model (MSCI MAC Factor Model), a multi-tiered model that helps investors analyze key portfolio exposures across asset classes through an integrated and consistent framework. Over the last decade, technology, regulatory changes, and the popularity of passive investments have continued to disrupt the active...